Impaired adipose tissue (AT) lipid handling and inflammation is associated with obesity-related
metabolic diseases. Circulating lipopolysaccharides (LPSs) from gut microbiota (…

BACKGROUND AND PURPOSE Glucagon-like peptide-1 (GLP-1) analogues improve glycaemic
control in type 2 diabetic (T2D) patients and cause weight loss in obese subjects by as …

MicroRNAs (miRNAs) are promising drug targets for obesity and metabolic disorders. Recently,
miRNA mimics are providing a unique mechanism of action that guides the process for …

Discordant phenotypes, metabolically healthy obese and unhealthy normal-weight individuals,
are always interesting to provide important insights into the mechanistic link between …

The endocannabinoid system (ECS) is an intercellular signalling mechanism that is present
in the islets of Langerhans and plays a role in the modulation of insulin secretion and …

Objective This study aimed to analyze the potential association of different microRNA (miRNA)
molecules with both type 2 diabetes (T2D) and obesity and determine their target genes. …

Context: The decreased expansion capacity of adipose tissue plays a crucial role in the onset
of disorders associated with metabolic syndrome. Objective: The aim of this study was to …

Multiple studies have suggested that the reduced differentiation capacity of multipotent
adipose tissue-derived mesenchymal stem cells (ASCs) in obese subjects could compromise …

Real-time or quantitative PCR (qPCR) is a useful technique that requires reliable reference
genes for data normalization in gene expression analysis. Adipogenesis is among the …

Despite the abundance of registered clinical trials worldwide, the availability of effective drugs
for obesity treatment is limited due to their associated side effects. Thus, there is growing …